OJQ
- 产品代码
- OJQ
- 器械名称
- Cardiac Allograft Gene Expression Profiling Test System
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 862.1163
- FDA 专业组
- Cardiovascular
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 2 件
FDA 分类定义
In vitro diagnostic multivariate index assay (ivdmia) test service, performed in a single laboratory, for assessing the gene expression profile of rna isolated from peripheral blood mononuclear cells (pbmc) and indicated for use to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (acr) at the time of testing in conjunction with standard clinical assessment.
该代码近三年的 510(k)(1 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K221640 | 2023-09-13 | Caredx, Inc. | AlloMap Heart Molecular Expression Testing |
FDA 官方分类页: OJQ
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。